We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+8%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$161M
AUM Growth
+$1.25M
(+0.78%)
Cap. Flow
+$68.4K
Cap. Flow
% of AUM
0.04%
Top 10 Holdings %
Top 10 Hldgs %
51.76%
Holding
60
New
21
Increased
7
Reduced
10
Closed
9
Top Buys
| 1 |
Cardinal Health
CAH
|
+$7.19M |
| 2 |
Cigna
CI
|
+$6.79M |
| 3 |
Humana
HUM
|
+$5.21M |
| 4 |
Rigel Pharmaceuticals
RIGL
|
+$4.98M |
| 5 |
HCA Healthcare
HCA
|
+$4.54M |
Top Sells
| 1 |
Gyre Therapeutics
GYRE
|
+$15.9M |
| 2 |
Sanofi
SNY
|
+$10.2M |
| 3 |
Biogen
BIIB
|
+$8.73M |
| 4 |
Viking Therapeutics
VKTX
|
+$6.62M |
| 5 |
Eli Lilly
LLY
|
+$6.37M |
Sector Composition
| 1 | Healthcare | 89.68% |
| 2 | Financials | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kura Oncology
KURA
$1.01B
| $15.2M | 9.45% |
837,604
+180,193
| +27% | +$3.05M |
|
2
Elevance Health
ELV
$84.8B
| $10.4M | 6.43% |
43,601
-8,786
| -17% | -$2.03M |
|
|
3
HCA Healthcare
HCA
$84B
| $9.98M | 6.18% |
97,230
+44,900
| +86% | +$4.54M |
|
|
LITS
4
Lite Strategy Inc
LITS
$33.7M
| $8.61M | 5.33% |
109,199
+62,471
| +134% | +$3.83M |
|
5
Icon
ICLR
$13.3B
| $7.33M | 4.54% |
55,332
+19,132
| +53% | +$2.38M |
|
|
AET
6
DELISTED
Aetna Inc
AET
| $7.18M | 4.45% |
39,135
+7,500
| +24% | +$1.34M |
|
|
7
Cigna
CI
$78.8B
| $6.66M | 4.13% |
+39,200
| New | +$6.79M |
|
|
8
Cardinal Health
CAH
$52.7B
| $6.19M | 3.84% |
+126,770
| New | +$7.19M |
|
|
9
Sanofi
SNY
$105B
| $6M | 3.72% |
150,058
-258,563
| -63% | -$10.2M |
|
10
Boston Scientific
BSX
$64B
| $5.97M | 3.7% |
182,633
-42,830
| -19% | -$1.29M |
|
|
11
Gyre Therapeutics
GYRE
$731M
| $5.5M | 3.41% |
62,860
-90,472
| -59% | -$15.9M |
|
|
12
Humana
HUM
$49B
| $5.3M | 3.28% |
+17,793
| New | +$5.21M |
|
13
Philips
PHG
$26.3B
| $4.3M | 2.66% |
131,075
+29,974
| +30% | +$958K |
|
14
Novartis
NVS
$288B
| $4.16M | 2.57% |
+61,380
| New | +$4.24M |
|
|
15
Rigel Pharmaceuticals
RIGL
$762M
| $3.96M | 2.45% |
+139,862
| New | +$4.98M |
|
16
Willis Towers Watson
WTW
$26.9B
| $3.94M | 2.44% |
+25,969
| New | +$3.95M |
|
17
Universal Health Services
UHS
$8.96B
| $3.94M | 2.44% |
+35,323
| New | +$4.14M |
|
18
Revvity
RVTY
$12.4B
| $3.85M | 2.39% |
+52,620
| New | +$3.95M |
|
19
electroCore
ECOR
$50M
| $3.52M | 2.18% |
+14,241
| New | +$3.87M |
|
|
CELG
20
DELISTED
Celgene Corp
CELG
| $3.33M | 2.06% |
41,942
+10,762
| +35% | +$894K |
|
|
SPPI
21
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $3.01M | 1.86% |
+143,550
| New | +$2.66M |
|
|
MRTX
22
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.96M | 1.83% |
+60,050
| New | +$2.27M |
|
23
Alnylam Pharmaceuticals
ALNY
$37.3B
| $2.94M | 1.82% |
+29,835
| New | +$2.96M |
|
24
Incyte
INCY
$23B
| $2.81M | 1.74% |
+42,000
| New | +$2.87M |
|
|
RVNC
25
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.78M | 1.72% |
+101,292
| New | +$3.04M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA